Add Yahoo as a preferred source to see more of our stories on Google. Juvéderm Voluma XC, one of several hyaluronic acid-based injectables under Allergan's umbrella of Juvéderm fillers, has been a ...

Please provide your email address to receive an email when new articles are posted on . “Because there are no permanent adverse reactions or deforming reactions, I think the safety is assured,” Karen ...

IRVINE, Calif.--(BUSINESS WIRE)--Allergan, Inc., (NYSE:AGN) today announced that the company has received approval from the U.S. Food and Drug Administration (FDA) to market JUVÉDERM VOLUMA™ XC, the ...

Dermatologists and plastic surgeons have a new, nonsurgical weapon to add to their anti-aging arsenal. Juvéderm Voluma XC was approved by the U.S. Food and Drug Administration in December as the first ...

EUGENE, Ore., Aug. 8, 2014 /PRNewswire/ -- Not long ago, if you wanted to restore a youthful shape to aging, hollowed cheeks, options for doing so without a surgical procedure were extremely limited.

Please provide your email address to receive an email when new articles are posted on . The FDA has approved Juvéderm Voluma XC as a filler to temporarily correct age-related loss in the cheeks of ...

We’ve been telling you about the much anticipated arrival of Juvéderm Voluma™ XC for quite some time and it is finally here. The first filler specifically developed for the cheek area, Juvéderm ...

The US Food and Drug Administration (FDA) has approved Juvéderm Voluma XC (Allergan) to correct age-related volume deficits in the midface in adults aged 21 years and older, the company announced ...